SCHEMBL30402091

SCHEMBL30402091

CCCc1cc(Br)c(C(=O)OC)nc1C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 1/20 0.39
GABRA5 P31644 1/20 0.39
GABRA3 P34903 1/20 0.39
GABRA2 P47869 1/20 0.39
GABRA6 Q16445 1/20 0.39
NPSR1 Q6W5P4 2/20 0.39
PDE10A Q9Y233 1/20 0.38
GRM1 Q13255 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
HPGD P15428 3/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
ATM Q13315 1/20 0.36
XDH P47989 1/20 0.35
CCR6 P51684 1/20 0.35
HKDC1 Q2TB90 1/20 0.35
PPARG P37231 2/20 0.34
PPARA Q07869 2/20 0.34
MTNR1A P48039 1/20 0.34
MTNR1B P49286 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25191584 1.00 GABRA1 (0.39) GABRA1GABRA5GABRA3GABRA2GABRA6
SCHEMBL25194933 0.73 ALDH1A1 (0.34) GRM1SMN1; SMN2KDM4EALDH1A1MEN1
SCHEMBL3597060 0.72 MAPK1 (0.41) GABRA1GABRA5GABRA3GABRA2GABRA6
SCHEMBL22890025 0.71 NPSR1 (0.47) GABRA1GABRA5GABRA3GABRA2GABRA6
SCHEMBL13755836 0.71 NPSR1 (0.38) GABRA1GABRA5GABRA3GABRA2GABRA6
SCHEMBL31431795 0.70 POLB (0.40) GABRA2NPSR1SMN1; SMN2HPGDKDM4E
SCHEMBL19243186 0.70 CYP1A2 (0.35) NPSR1SMN1; SMN2KDM4EALDH1A1PPARG
SCHEMBL31432429 0.69 NPSR1 (0.48) NPSR1SMN1; SMN2HPGDKDM4EALDH1A1
SCHEMBL27388974 0.69 NPSR1 (0.44) NPSR1SMN1; SMN2HPGDKDM4EALDH1A1
SCHEMBL25199463 0.68 ALDH1A1 (0.32) ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4430022-A1 HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE Vigil Neuroscience, Inc. (US) 2024-09-18 EP disclosed
WO-2023086801-A1 HETEROCYCLIC COMPOUNDS AS TRIGGERING RECEPTOR EXPRESSED ON MYELOID CELLS 2 AGONISTS AND METHODS OF USE VIGIL NEUROSCIENCE, INC. (US) 2023-05-19 WO disclosed